Retrophin to Report Third Quarter 2020 Financial Results
21 Octubre 2020 - 3:30PM
Retrophin, Inc. (NASDAQ: RTRX) today announced it will report third
quarter 2020 financial results on Thursday, November 5, 2020 after
the close of the U.S. financial markets. The Company will host a
conference call and webcast to discuss the financial results and
provide a general business update at 4:30 p.m. ET.
Conference
Call Information |
|
|
Date: |
Thursday, November 5,
2020 |
Time: |
4:30 p.m. ET |
Dial-in numbers: |
+1 (855) 219-9219 (U.S.) or +1
(315) 625-6891 (International) |
Confirmation code: |
7362327 |
Live webcast: |
Retrophin.com in the “Events
& Presentations” section of the “Investors” page |
A replay of the call will be available from 7:30
p.m. ET, November 5, 2020 to 7:30 p.m. ET, November 12, 2020. The
replay number is +1 (855) 859-2056 (U.S.) or +1 (404) 537-3406
(International), confirmation code 7362327.
About Retrophin
Retrophin is a biopharmaceutical company
specializing in identifying, developing and delivering
life-changing therapies to people living with rare disease. The
Company’s approach centers on its pipeline featuring sparsentan, a
product candidate in late-stage development for focal segmental
glomerulosclerosis (FSGS) and IgA nephropathy (IgAN), rare
disorders characterized by progressive scarring of the kidney often
leading to end-stage renal disease. Research in additional rare
diseases is also underway, including partnerships with leaders in
patient advocacy and government research to identify potential
therapeutics for NGLY1 deficiency and Alagille syndrome, conditions
with no approved treatment options. Retrophin’s R&D efforts are
supported by revenues from the Company’s commercial products
Chenodal®, Cholbam®, Thiola® and Thiola EC®.
Retrophin.com
Contact:Chris Cline, CFASenior Vice President,
Investor Relations & Corporate
Communications888-969-7879IR@retrophin.com
Retrophin (NASDAQ:RTRX)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Retrophin (NASDAQ:RTRX)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Retrophin Inc (NASDAQ): 0 recent articles
Más de Artículos de Noticias